120 NEWPORT CENTER DRIVE, NEWPORT BEACH, CA
Secures Five-Year Royalty Stream from Elevai Skincare Sale Under Executed Payment Agreement
Expands AI-Driven Drug Discovery Program with Yuva Biosciences, Advancing Four AI-Discovered Compounds Toward Lead Nomination in Cardiac Disease and Obesity
PMGC and Orbit2Orbit Partner for Spaceflight Study on Muscle Loss
Merger Agreement Between AGA Precision Systems LLC and A&B Aerospace, Inc.
Standard Exclusive License Agreement with NorthStrive Defense Tech
Announces Positive Results from Phase III of AI-Driven Drug Discovery Program with Yuva Biosciences
PMGC Holdings Inc. Amends Bylaws; Shareholder Approval Received
NorthStrive Defense Tech Enters Material Agreement with FSURF
Q2
Q1
FY 2025
Q3
FY 2024
Prospectus filed pursuant to Rule 424(b)(5)
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
Definitive Proxy Statement
PRE 14A
Definitive Information Statement
Preliminary Information Statement
Schedule 13D - Ownership Report
Statement of Changes in Beneficial Ownership
Amended Schedule 13D - Ownership Report
Correspondence